Literature DB >> 8244271

Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats.

K Fujiwara1, S Nagoshi, A Ohno, K Hirata, Y Ohta, S Mochida, T Tomiya, K Higashio, K Kurokawa.   

Abstract

Human hepatocyte growth factor stimulates DNA synthesis by cultured rat hepatocytes. When human hepatocyte growth factor prepared from the culture medium of human embryonic lung fibroblasts was intravenously injected into normal rats and rats after 70% hepatectomy, it was detected in hepatocytes but not in nonparenchymal cells isolated 30 min after injection. Similar injections of human hepatocyte growth factor at 2-hr intervals for 10 hr significantly increased hepatic DNA content in normal rats at 48 hr, with increased hepatic content of putrescine, the essential polyamine for hepatic DNA synthesis after 70% hepatectomy, and activities of catalytic enzymes of putrescine synthesis at 6 hr almost to the levels in rats after 70% hepatectomy. Those levels in rats after 70% hepatectomy were further enhanced by similar injections of human hepatocyte growth factor starting immediately after surgery. Increased hepatic DNA content in normal rats and rats after 70% hepatectomy was also seen with recombinant human hepatocyte growth factor to a greater extent compared with that seen with human hepatocyte growth factor. In normal rats given recombinant human hepatocyte growth factor, 5-bromo-2'-deoxyuridine-labeled and mitotic hepatocytes were significantly increased in number at 26 hr but not at 48 hr. We conclude that exogenous human hepatocyte growth factor acts as a trigger and a promoter of liver growth to increase hepatic putrescine production in rats. Recombinant human hepatocyte growth factor is more potent than human hepatocyte growth factor in this action.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244271

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  28 in total

Review 1.  Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.

Authors:  Hussein-M Atta
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

2.  Gene transfer of c-met confers protection against D-galactosamine/lipopolysaccharide-induced acute liver failure.

Authors:  Chuanlong Zhu; Yuwen Li; Wenting Li; Quan Wu; Rentao Gao
Journal:  Dig Dis Sci       Date:  2012-01-24       Impact factor: 3.199

3.  Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  Hiroki Tojima; Satoru Kakizaki; Takashi Kosone; Norio Horiguchi; Yuichi Yamazaki; Ken Sato; Hitoshi Takagi; Masatomo Mori
Journal:  Hepatol Int       Date:  2011-08-05       Impact factor: 6.047

4.  Expression of transforming growth factor-alpha and its receptor during human liver development and maturation.

Authors:  T Terada; T Ohta; Y Nakanuma
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.

Authors:  Norimasa Miura; Hiroko Kabashima; Mika Shimizu; Reina Sato; Tomoe Tsukamoto; Tomomi Harada; Shunsaku Takahashi; Ryujin Endo; Nobuaki Nakayama; Yasuhiro Takikawa; Satoshi Mochida; Kazuyuki Suzuki; Junichi Hasegawa; Goshi Shiota
Journal:  Hepatol Int       Date:  2008-04-09       Impact factor: 6.047

6.  Interlocking triads of growth control in tumors.

Authors:  S Michelson; J T Leith
Journal:  Bull Math Biol       Date:  1995-03       Impact factor: 1.758

7.  An implantable vascularized protein gel construct that supports human fetal hepatoblast survival and infection by hepatitis C virus in mice.

Authors:  Martha J Harding; Christin M Lepus; Thomas F Gibson; Benjamin R Shepherd; Scott A Gerber; Morven Graham; Frank X Paturzo; Christoph Rahner; Joseph A Madri; Alfred L M Bothwell; Brett D Lindenbach; Jordan S Pober
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Role of protein kinase a pathway in epidermal growth factor-induced liver cell repair.

Authors:  M Kikuchi; T Y Ma; A S Tarnawski; H Shimada; I J Sarfeh
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

9.  Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.

Authors:  Yasuhiro Hayashi; Ryoichi Mizuno; Khalil A Ikramy; Hidetaka Akita; Hideyoshi Harashima
Journal:  Nucleic Acid Ther       Date:  2012-09-10       Impact factor: 5.486

10.  Effect of granulocyte-macrophage colony-stimulating factor on hepatic regeneration after 70% hepatectomy in normal and cirrhotic rats.

Authors:  A Eroğlu; S Demirci; H Akbulut; N Sever; S Demirer; A E Unal
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.